
Investment group financing circular economy companies from seed stage to private equity and infrastructure

European healthcare-focused investment firm backing companies from start-up stage to established growth businesses

Registered with the French markets regulator, Merieux Equity Partners invests in healthcare, life science and nutrition companies through two platforms, and has done so since 2009.
The Innovation platform funds medical breakthroughs early on, running from seed to Series B, and aims to support companies with ambitious growth projects and products that could transform health. Its sector focus is healthcare, life science and nutrition, across both platforms. Its current vehicle, Merieux Innovation 2, is raising capital.
The Buyout platform targets profitable, quickly expanding businesses and backs their plans for development. Its current vehicle, Merieux Participations 5, has announced a first closing.
The firm works as an independent, multi-stage investor. The team brings long experience in investment and in running businesses, and portfolio companies gain access to its sector expertise and international contacts.
Recent investments include HighLife Medical, a French medical technology company, made through Innovation 2, and Ona Therapeutics, a Spanish biopharmaceutical company. The firm has also acquired a majority stake in Curea Medical.
The firm manages third-party capital and reports a team of 18 investment professionals in two offices. It reports more than 60 investments in total and has supported more than 45 companies in Europe and North America. Each of these deals sits within the platform structure described above.
Merieux Equity Partners is an investment firm that specialises in healthcare, life science and nutrition. Created in 2009, it manages capital from outside investors and is registered with the French markets regulator, the AMF.
Healthcare and nutrition companies ranging from start-ups to established players, in Europe and North America. The firm says it has supported more than 45 companies and lists over 60 investments overall. Recent deals include stakes in a French medical technology company, a Spanish biopharmaceutical business and a majority holding in Curea Medical.
Summary written by TrustList from the business's own published information, Nov 2026.
Merieux Equity Partners is ranked on 6 TrustList rankings: #8 on 1, #18 on 1, #19 on 1, #21 on 1, #23 on 1 and #24 on 1.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Merieux Equity Partners has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
It is the only one of the top 71 here listing private equity and one of 5 here listing industrial.
Its profile: “The Innovation platform funds medical breakthroughs early on, running from seed to Series B, and aims to support companies with ambitious growth projects and products that could transform health.”
Of the top 71 here, 42 also cover series and 31 also cover series a; 8 also work in London and 6 also work in New York City.
Behind Inter-Atlantic Group, ahead of Middle East Venture Partners (MEVP).
It is one of 3 here listing science and one of 4 here listing series b.
Its profile: “- Innovation platform: backs medical innovation from seed stage to series B.”
Of the top 54 here, 18 also cover pre seed and 10 also cover partners; 8 also work in Silicon Valley and 7 also work in San Francisco.
Behind Seedcamp.
It is one of 2 here listing healthtech and one of 5 here listing series.
Of the top 65 here, 7 also cover private equity and 7 also cover environmental; 10 also work in Munich and 9 also work in Madrid.
Ahead of InnovaFonds.
It is the only one of the top 57 here listing seed stage and one of 3 here listing series a.
Of the top 57 here, 12 also cover healthtech and 6 also cover growth stage; 5 also work in Chicago and 3 also work in United States.
Behind TZP Group.
It is one of 13 here listing partners.
Of the top 57 here, 21 also cover seed stage and 9 also cover early stage; 4 also work in Sao Paulo and 3 also work in Europe.
Ahead of Knife Capital.
It is the only one of the top 64 here listing industrial and one of 6 here listing private equity.
Of the top 64 here, 14 also cover biotech and 10 also cover artificial intelligence; 7 also work in Boston and 6 also work in Hong Kong.
Behind Beecken Petty O’Keefe & Company.
As of 2026-11-16. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Merieux Equity Partners.
Similar listings buyers compare against this one.

Investment group financing circular economy companies from seed stage to private equity and infrastructure

An early-stage venture fund known among founders for its network and hands-on support

Africa-focused seed venture firm backing tech founders digitising traditional industries

New York venture firm investing in early-stage and growth companies across enterprise and consumer sectors

New York real estate investment firm that also invests in venture capital and data centres

Asia-based private investment group with interests in technology, media, telecoms, financial services and property

Middle-market private equity firm investing in industrial, healthcare and technology businesses in North America and Europe

Pan-African early-stage venture firm backing tech-enabled startups led by African founders
Everything here links back to the same verified catalogue. Pick your next stop.